Invus Global Management, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Invus Public Equities, L.P.
Security
Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KLRS
Shares outstanding
18,839,067 shares
Disclosed Ownership
282,586 shares
Ownership
1.5%
Form type
SCHEDULE 13G/A
Filing time
29 Jul 2025, 13:21:24 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 1.5% ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS) on 30 Jun 2025."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G/A for Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS).
  • Disclosed ownership: 1.5%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 29 Jul 2025, 13:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 1.5% 282,586 282,586 0 /s/ Raymond Debbane Raymond Debbane

Sponsored